SOL-GEL TECHNOLOGIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.94 USD | +4.43% |
|
+11.89% | -14.93% |
| Mar. 13 | Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 29 | Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director | CI |
Chart calendar Sol-Gel Technologies Ltd.
3112208d79f8039c65840835678218.PQNSLqJEoNZzs_RGFYnwbpry9rqs-WEFcJiYA8lhges.RUsXV_MC5aMnxYIveseaJtTKw-j4nyBROvrhWZ0V-bFbQBVd8XTYjEfRzA~e00a14a55f93018c1be9b5efb8e5fe0a
Upcoming events on Sol-Gel Technologies Ltd.
Past events on Sol-Gel Technologies Ltd.
| 2024-03-13 07:00 am | Q4 2023 Earnings Release |
| 2023-12-06 12:00 pm | Investor Meeting - Key Opinion Leader |
| 2023-11-09 07:00 am | Q3 2023 Earnings Release |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-10 07:00 am | Q2 2023 Earnings Release |
| 2023-07-26 09:00 am | Annual General Meeting |
| 2023-05-12 07:00 am | Q1 2023 Earnings Release |
| 2023-03-30 08:30 am | H.C. Wainwright Autoimmune & Inflammatory Disease Conference |
| 2023-03-10 07:00 am | Q4 2022 Earnings Release |
| 2023-01-27 08:30 am | Acquisition of Patidegib by Sol-Gel Technologies Ltd Call |
| 2022-11-10 04:00 am | Q3 2022 Earnings Release |
| 2022-08-04 06:00 am | Interim 2022 Earnings Release |
| 2022-06-08 08:30 am | Jefferies Healthcare Conference |
| 2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-19 09:00 am | Annual General Meeting |
| 2022-05-13 07:00 am | Q1 2022 Earnings Release |
| 2022-03-30 07:00 am | FY 2021 Earnings Release |
| 2022-03-25 10:30 am | American Academy of Dermatology Meeting |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2022-01-04 | LifeSci Partners Corporate Access Event |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,9 22,8 0.24% | 8,77 8,30 5.74% | 31,3 30,8 1.51% | 3,88 5,68 -31.64% | 1,55 1,17 32.71% | 2,40 |
|
EBITDA Million USD | Released Forecast Spread | -25,1 -27,9 10.15% | -28,1 -37,2 24.54% | 4,53 -2,69 268.18% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -26,0 -26,6 2.3% | -30,2 -34,7 12.92% | 2,96 0,74 303.08% | -16,2 -12,6 -28.63% | -29,3 -29,2 -0.25% | -21,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,6 -24,9 1.5% | -29,3 -33,8 13.28% | 3,22 1,15 180.9% | -14,9 -11,7 -27.35% | -27,2 -28,2 3.52% | -19,7 |
|
Net income Million USD | Released Forecast Spread | -24,6 -24,9 1.37% | -29,3 -33,8 13.25% | 3,22 1,15 180.9% | -14,9 -11,7 -27.35% | -27,2 -27,3 0.35% | -19,7 |
|
EPS USD | Released Forecast Spread | -1,26 -1,30 3.23% | -1,30 -1,48 12.31% | 0,14 0,05 180% | -0,65 -0,50 -29.14% | -1,01 -1,01 0% | -0,70 |
| Announcement Date | 24/03/20 | 04/03/21 | 30/03/22 | 10/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,8 17,7 17.86% | 0,00 1,40 -99.79% | 3,52 4,61 -23.68% | 0,26 3,45 -92.44% | 0,10 1,84 -94.56% | 0,76 0,48 59.58% | 0,59 1,55 -61.76% | 0,21 0,69 -69.24% | 0,45 0,27 67.1% | 1,30 | 0,30 | 0,40 | 0,40 |
|
EBIT Million USD | Released Forecast Spread | 14,0 9,36 49.16% | -5,95 -6,83 12.93% | -0,46 -2,36 80.36% | -3,63 -1,65 -120.23% | -6,21 -3,01 -106.11% | -10,6 -5,93 -78.99% | -6,53 -7,20 9.3% | -6,31 -6,61 4.55% | -5,41 -5,33 -1.4% | -4,70 | -5,60 | -5,40 | -5,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 14,0 9,45 48.46% | -5,60 -6,82 17.91% | -0,13 -2,25 94.03% | -3,41 -1,50 -126.98% | -5,79 -2,89 -100.49% | -10,3 -5,59 -83.76% | -5,97 -6,88 13.25% | -5,71 -6,31 9.46% | -4,84 -5,08 4.85% | -4,20 | -5,20 | -5,10 | -5,20 |
|
Net income Million USD | Released Forecast Spread | 14,0 9,45 48.46% | -5,60 -6,82 17.91% | -0,13 -2,25 94.03% | -3,41 -1,50 -126.98% | -5,79 -2,89 -100.49% | -10,3 -5,59 -83.76% | -5,97 -6,88 13.25% | -5,71 -6,31 9.46% | -4,84 -4,93 1.96% | -4,20 | -5,20 | -5,10 | -5,20 |
|
EPS USD | Released Forecast Spread | 0,61 0,51 18.83% | -0,24 -0,29 17.24% | -0,01 -0,10 89.66% | -0,15 -0,07 -130.77% | -0,25 -0,13 -100% | -0,41 -0,22 -90.7% | -0,22 -0,26 13.73% | -0,21 -0,23 8.7% | -0,17 -0,18 2.86% | -0,15 | -0,17 | -0,18 | -0,18 |
| Announcement Date | 30/03/22 | 13/05/22 | 04/08/22 | 10/11/22 | 10/03/23 | 12/05/23 | 10/08/23 | 09/11/23 | 13/03/24 | - | - | - | - |
More events
Past sector events for Sol-Gel Technologies Ltd.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLGL Stock
- Calendar Sol-Gel Technologies Ltd.
